Pharmasset, Inc. (VRUS) JP Morgan raised Pharmasset’s price target to $200 based on building momentum for the nuc class of Hep C therapies following the recent EASL – Massive upgrade – stock trading 102.55 up 5 in the pre market Post Market Headlines United States Oil Fund LP (USO) GS Raises its year end target for crude to $130/barrel last night Watch my video “On the Wire”…
View the full post at http://blog.t3live.com
